Conduent Uses GenAI to Transform Reportable Event Detection and Strengthen FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global company specializing in technology-driven business solutions, announced a new Generative AI-powered platform designed to streamline the identification of reportable events in the pharmaceutical and life sciences sectors.
The system, built on Microsoft Azure OpenAI technology, enhances automation for detecting and managing critical compliance events across all customer communication channels. This approach helps organizations meet regulatory standards more efficiently while improving overall data accuracy and processing speed.
Key Objectives
- Automate detection of reportable events across multi-channel interactions.
- Improve accuracy and minimize human error in compliance procedures.
- Help pharmaceutical and life sciences companies meet evolving FDA requirements.
Media and Investor Contacts
- Media: Sean Collins, Conduent – +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent – [email protected]
"Powered by Microsoft Azure OpenAI, this solution represents a new era in compliant, AI-driven automation for regulated industries."
Author’s Summary
Conduent has unveiled an Azure-based GenAI tool that automates event detection for pharma compliance, setting a modern benchmark in regulatory technology.